SecurityHIL / Hill International, Inc. (431466101)
President and CEORichter David L
IndustryEngineering Services
Institutional Owners67
Institutional Shares37,071,784 - 67.04%
Common Shares Outstanding55,294,670 shares (as of 2017-12-31)
Institutional Value$ 325,848,000 USD

Institutional Stock Ownership and Shareholders

HIL / Hill International, Inc. Institutional Ownership

Hill International, Inc. (NYSE:HIL) has 67 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,071,784 shares. Largest shareholders include Engine Capital Management, LLC, Bulldog Investors, LLC, Ancora Advisors, LLC, BlackRock Inc., Vanguard Group Inc, Petrus Trust Company, LTA, Dimensional Fund Advisors Lp, Thomson Horstmann & Bryant Inc, 22nw, Lp, and BlackRock Fund Advisors.
Hill International, Inc. (NYSE:HIL) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 24,900 37,500 50.60 142 221 55.63
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 62,000 104,887 69.17 354 619 74.86
2018-08-10 13F-HR THOMSON HORSTMANN & BRYANT INC 1,910,197 1,913,497 0.17 10,888 11,289 3.68
2017-02-10 13F-HR BlackRock Advisors LLC 18,532 19,931 7.55 85 87 2.35
2018-08-13 13F-HR Bulldog Investors, LLC 3,570,458 3,611,055 1.14 20,352 21,305 4.68
2018-08-13 13F-HR Axa 17,700 10,100 -42.94 101 60 -40.59
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 851 5
2018-08-06 13F-HR RHUMBLINE ADVISERS 29,430 44,065 49.73 168 260 54.76
2018-07-31 13F-HR Lapides Asset Management, LLC 268,800 133,900 -50.19 1,532 790 -48.43
2018-08-07 13F-HR RUTABAGA CAPITAL MANAGEMENT LLC/MA 895,500 929,600 3.81 5,104 5,485 7.46
2018-08-06 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 15,851 15,851 0.00 90 94 4.44
2017-08-14 13F-HR Tappan Street Partners LLC 558,470 900,000 61.15 2,318 4,680 101.90
2018-08-14 13F-HR TWO SIGMA ADVISERS, LP 19,600 23,900 21.94 112 141 25.89
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 21,812 31,928 46.38 124 188 51.61
2018-08-14 13F-HR Petrus Trust Company, LTA 2,263,527 2,117,235 -6.46 12,902 12,492 -3.18
2018-08-14 13F-HR Engine Capital Management, LLC 5,179,891 5,179,891 0.00 29,525 30,561 3.51
2018-08-10 13F-HR CITIGROUP INC 2,867 16,411 472.41 16 97 506.25
2018-08-14 13F-HR CREDIT SUISSE AG/ 12,444 12,591 1.18 71 74 4.23
2018-08-10 13F-HR 22NW, LP 1,764,158 1,764,158 0.00 10,056 10,409 3.51
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 1,067,329 1,006,445 -5.70 6,084 5,938 -2.40
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 200,559 121,835 -39.25 1,143 719 -37.10
2018-08-14 13F-HR MORGAN STANLEY 75,003 113,542 51.38 428 670 56.54
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 2,082,259 2,106,693 1.17 11,869 12,430 4.73
2018-08-14 13F-HR DEUTSCHE BANK AG\ 111,603 271,681 143.44 635 1,602 152.28
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 7,202 9,876 37.13 41 58 41.46
2017-02-10 13F-HR BlackRock Investment Management, LLC 145,941 142,221 -2.55 673 619 -8.02
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 0 18,842 0 111
2018-08-13 13F-HR Stone Ridge Asset Management LLC 65,094 65,094 0.00 371 384 3.50
2018-08-15 13F-HR Metlife Investment Advisors, Llc 24,384 144
2018-07-19 13F-HR Foundry Partners, LLC 586,705 591,655 0.84 3,344 3,491 4.40
2018-08-14 13F-HR MENTA CAPITAL LLC 20,746 0 -100.00 118 0 -100.00
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 81,240 102,240 25.85 463 603 30.24
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 0 1,133 0 7
2018-07-20 13F-HR Creative Planning 108,500 108,500 0.00 618 640 3.56
2018-08-10 13F-HR Ancora Advisors, LLC 2,453,747 3,227,504 31.53 13,987 19,042 36.14
2018-08-08 13F-HR KOKINO LLC 158,996 159,309 0.20 906 940 3.75
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 37,432 33,734 -9.88 213 199 -6.57
2018-07-26 13F-HR TCI Wealth Advisors, Inc. 437 437 0.00 2 3 50.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 5,400 5,491 1.69 31 33 6.45
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 29,201 44,360 51.91 167 261 56.29
2018-08-14 13F-HR HAWK RIDGE CAPITAL MANAGEMENT LP 612,500 612,500 0.00 3,491 3,614 3.52
2018-08-14 13F-HR BARCLAYS PLC 7,078 3,589 -49.29 40 21 -47.50
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 1,168 0 -100.00 7 0 -100.00
2018-08-14 13F-HR VANGUARD GROUP INC 1,874,853 2,162,360 15.33 10,687 12,758 19.38
2018-08-02 13F-HR NJ State Employees Deferred Compensation Plan 110,000 120,000 9.09 627 708 12.92
2018-08-14 13F-HR Voya Investment Management LLC 18,616 18,616 0.00 106 110 3.77
2018-08-14 13F-HR STATE STREET CORP 541,967 724,822 33.74 3,089 4,277 38.46
2017-02-10 13F-HR BlackRock Fund Advisors 906,612 1,059,576 16.87 4,179 4,609 10.29
2018-08-09 13F-HR BlackRock Inc. 2,301,877 3,176,892 38.01 13,120 18,743 42.86
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 12,194 30,505 150.16 70 180 157.14
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 52,704 75,002 42.31 300 443 47.67
2018-08-13 13F-HR ALLIANCEBERNSTEIN L.P. 13,100 77
2018-08-13 13F-HR MAVEN SECURITIES Ltd 107,170 638
2018-08-14 13F-HR PERRITT CAPITAL MANAGEMENT INC 994,140 994,140 0.00 5,617 5,865 4.42
2018-08-14 13F-HR UBS Group AG 927 7,855 747.36 5 46 820.00
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 201,551 201,551 0.00 1,149 1,189 3.48
2018-08-14 13F-HR TEACHERS ADVISORS INC 65,570 84,638 29.08 374 499 33.42
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 2,159 4,067 88.37 12 24 100.00
2018-08-06 13F-HR STRS OHIO 114,900 114,900 0.00 654 677 3.52
2018-08-14 13F-HR Invesco Ltd. 76,743 77,439 0.91 437 457 4.58
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,051,514 1,051,514 0.00 4,847 4,574 -5.63
2018-09-18 13F-HR/A NORTHERN TRUST CORP 424,926 554,373 30.46 2,422 3,271 35.05
2018-08-14 13F-HR JP Morgan Chase & Co 35,139 10,199 -70.98 200 60 -70.00
2018-08-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 17,220 101,598
2018-05-11 13F-HR CITIGROUP INC 290 2,867 888.62 2 16 700.00
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 6,693 1,673 -75.00 38,150 9,871 -74.13
2018-05-11 13F-HR Delpha Capital Management, Llc 205 0 -100.00 1 0 -100.00
2018-08-10 13F-HR Legal & General Group Plc 6,480 7,305 12.73 37 43 16.22
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 277,655 404,739 45.77 1,582 2,387 50.88
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 3,297 3,645 10.56 19 21 10.53
2018-08-13 13F-HR Renaissance Technologies LLC 407,200 2,321

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

18h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

Related News Stories

Scomi Group, YTL Hospitality REIT, Serba Dinamik, Perstima, Globetronics, Opcom, Halex and Datasonic

2018-07-31 theedgemarkets
KUALA LUMPUR (July 31): Based on corporate announcements and news flow today, companies in focus on Wednesday (Aug 1) may include: Scomi Group Bhd, YTL Hospitality Real Estate Investment Trust (REIT), Serba Dinamik Holdings Bhd, Perusahaan Sadur Timah Malaysia Bhd, Globetronics Technology Bhd, Opcom Holdings Bhd, Halex Holdings Bhd and Datasonic Group Bhd.

Serba Dinamik collaborates with Hill International for Pengerang project

2018-07-31 theedgemarkets
KUALA LUMPUR (July 31): Serba Dinamik Holdings Bhd has inked a heads of agremeent (HoA) with Hill International N.V to jointly undertake the proposed development of the Pengerang International Commercial Centre (PICC) in Pengerang, Johor.

BRIEF-Hill International Announces Restatement Filing

2018-05-08 reuters
* HILL INTERNATIONAL INC - PLANS TO FILE ITS QUARTERLY REPORTS ON FORM 10-Q FOR QUARTERS ENDED JUNE 30 AND SEPTEMBER 30, 2017, BY END OF Q2 OF 2018 (1-1)

BRIEF-Hill International Expands Presence In India With Multiple Rail / Metro Project Selections

2018-05-03 reuters
* HILL INTERNATIONAL INC - AWARDS HAVE A TOTAL PROJECT VALUE ESTIMATED AT NEARLY $4 BILLION (1-0)

BRIEF-Hill International Reiterates Previously Issued 2018 Guidance

2018-03-30 reuters
* HILL INTERNATIONAL - REITERATES PREVIOUSLY ISSUED 2018 GUIDANCE, EXPECTS CONSULTING FEE REVENUE BETWEEN $400 MILLION AND $415 MILLION FOR 2018 - SEC FILING Source text: (bit.ly/2GKDEAd) Further company coverage: (1-0)

CUSIP: 431466101